Mahaney Paige bought CCCC
October 28, 2025 · Form 4 insider transaction
Mahaney Paige bought 19,200 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,200
Price
$0.00
Total value
N/A
InsiderMahaney Paige
RoleOfficer
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 28, 2025
Filing dateOctober 30, 2025
Shares owned after105,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on October 28, 2024.